Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aytu Biopharma Inc (NQ: AYTU ) 2.750 UNCHANGED Streaming Delayed Price Updated: 3:59 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 2.750 Bid (Size) 2.750 (5) Ask (Size) 2.790 (15) Prev. Close 2.750 Today's Range 2.750 - 2.750 52wk Range 1.520 - 3.500 Shares Outstanding 5,567,490 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms June 18, 2024 Via ACCESSWIRE Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024 May 29, 2024 Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and... Via Newsfile Performance YTD -4.84% -4.84% 1 Month -6.78% -6.78% 3 Month -1.79% -1.79% 6 Month +0.36% +0.36% 1 Year +58.05% +58.05% More News Read More Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 May 23, 2024 Via ACCESSWIRE AYTU Stock Earnings: Aytu BioPharma Beats EPS, Beats Revenue for Q3 2024 May 15, 2024 Via InvestorPlace Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024 May 08, 2024 Via ACCESSWIRE Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024 April 03, 2024 Via ACCESSWIRE Earnings Scheduled For February 14, 2024 February 14, 2024 Via Benzinga Earnings Preview: Aytu BioPharma February 13, 2024 Via Benzinga Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023 November 30, 2023 Via ACCESSWIRE Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter February 14, 2024 Via ACCESSWIRE Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024 February 07, 2024 Via ACCESSWIRE Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024 January 23, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Wednesday's After-Market Session November 22, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session November 15, 2023 Via Benzinga Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results November 14, 2023 Via ACCESSWIRE Aytu BioPharma's Earnings: A Preview November 13, 2023 Via Benzinga Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year November 08, 2023 Via ACCESSWIRE Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 15, 2023 Via Benzinga Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023 November 07, 2023 Via ACCESSWIRE Biggest Short Squeeze Stocks Of The Week: Biotech Stocks Dominate, A Bitcoin-Related Stock Moves Up Leaderboard November 06, 2023 Via Benzinga Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement October 26, 2023 Via ACCESSWIRE Aytu BioPharma Inc. (NASDAQ: AYTU) Near the Top of Equities by Percentage Gain on 9/28 September 28, 2023 Via Investor Brand Network Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023 October 09, 2023 Via ACCESSWIRE 12 Health Care Stocks Moving In Thursday's Intraday Session September 28, 2023 Via Benzinga Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session September 28, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
